Gert Matthijs
Center for Human Genetics
University of Leuven
Belgium
Name/email consistency: high
- The European opposition against the BRCA gene patents. Matthijs, G. Fam. Cancer (2006)
- Research network: EUROGLYCANET: a European network focused on congenital disorders of glycosylation. Matthijs, G. Eur. J. Hum. Genet. (2005)
- The prenatal diagnosis of congenital disorders of glycosylation (CDG). Matthijs, G., Schollen, E., Van Schaftingen, E. Prenat. Diagn. (2004)
- Congenital disorders of glycosylation. Matthijs, G. Trends Biochem. Sci. (2000)
- Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia). Matthijs, G., Schollen, E., Bjursell, C., Erlandson, A., Freeze, H., Imtiaz, F., Kjaergaard, S., Martinsson, T., Schwartz, M., Seta, N., Vuillaumier-Barrot, S., Westphal, V., Winchester, B. Hum. Mutat. (2000)
- Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A. Matthijs, G., Schollen, E., Van Schaftingen, E., Cassiman, J.J., Jaeken, J. Am. J. Hum. Genet. (1998)
- PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localized on chromosome 22q13. Matthijs, G., Schollen, E., Pirard, M., Budarf, M.L., Van Schaftingen, E., Cassiman, J.J. Genomics (1997)
- Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Matthijs, G., Schollen, E., Pardon, E., Veiga-Da-Cunha, M., Jaeken, J., Cassiman, J.J., Van Schaftingen, E. Nat. Genet. (1997)
- Evidence for genetic heterogeneity in the carbohydrate-deficient glycoprotein syndrome type I (CDG1). Matthijs, G., Legius, E., Schollen, E., Vandenberk, P., Jaeken, J., Barone, R., Fiumara, A., Visser, G., Lambert, M., Cassiman, J.J. Genomics (1996)
